Oncology - BMT/SCT News & Articles

81 Pursuing Self-Renewal and Pluripotency with the Stem Cell Factor Nanog Stem Cells, May 13, 2013    Clinical Article

82 Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplantation in Adults using Fludarabine, BCNU, Melphalan, and Antithymocyte Globulin (FBM-A): Outcomes depend on Disease Risk Index but not Age, Comorbidity Score, Donor Type, or HLA Mismatch Biology of Blood and Marrow Transplantation, May 13, 2013    Clinical Article

83 Trends in utilization and survival after autologous hematopoietic cell transplantation in North America from 1995 to 2005: Significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age Biology of Blood and Marrow Transplantation, May 13, 2013    Clinical Article

84 Prognostic value of telomere attrition in patients with aplastic anemia International Journal of Hematology, May 13, 2013    Review Article

85 Phase angle from BIA as a prognostic and nutritional status tool for children and adolescents undergoing hematopoietic stem cell transplantation Clinical Nutrition, May 10, 2013    Review Article

86 Non-relapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation Biology of Blood and Marrow Transplantation, May 10, 2013    Clinical Article

87 Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM) Leukemia Research, May 10, 2013    Clinical Article

88 Changes in nutritional status, body composition, quality of life, and physical activity levels of cancer patients undergoing autologous peripheral blood stem cell transplantation Supportive Care in Cancer, May 9, 2013    Review Article    Clinical Article

89 Reduced Oct4 Expression Directs a Robust Pluripotent State with Distinct Signaling Activity and Increased Enhancer Occupancy by Oct4 and Nanog Cell Stem Cell, May 9, 2013    Clinical Article

90 Pharmacologic Immunoablation followed by Reduced Toxicity conditioning and stem cell Transplantation in High Risk Thalassemia; A safe approach to disease control Biology of Blood and Marrow Transplantation, May 9, 2013    Clinical Article

91 A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation Bone Marrow Transplantation, May 9, 2013    Evidence Based Medicine    Review Article

92 Identification of Gene Microarray Expression Profiles in Patients with Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation Clinical Immunology, May 9, 2013    Clinical Article

93 Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem-cell transplantation: long-term results from a single institution Full Text Haematologica, May 8, 2013    Clinical Article

94 Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial Annals of Hematology, May 8, 2013    Clinical Article

95 mTOR Signaling in Hematopoietic Stem Cells and Leukemia Cancer Science, May 8, 2013    Clinical Article

96 Nelarabine for T-cell Acute Lymphoblastic Leukemia relapsing after allogeneic Hematopoietic Stem Cell Transplantation: an opportunity to improve survival Biology of Blood and Marrow Transplantation, May 8, 2013    Clinical Article

97 A phase I study of CPX-351 in combination with Busulfan and Fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia Biology of Blood and Marrow Transplantation, May 8, 2013    Clinical Article

98 To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century Bone Marrow Transplantation, May 8, 2013    Clinical Article

99 Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study Supportive Care in Cancer, May 7, 2013    Clinical Article

100 A model for the regulation of T-type Ca2+ channels in proliferation: roles in stem cells and cancer Expert Review of Anticancer Therapy, May 7, 2013    Review Article

1 Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation British Journal of Haematology, May 13, 2013

2 Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy Autoimmunity Reviews, May 21, 2013    Review Article

3 Mortality Rates of Human Metapneumovirus and Respiratory Syncytial Virus Lower Respiratory Tract Infections in Hematopoietic Cell Transplant Recipients Biology of Blood and Marrow Transplantation, May 21, 2013

4 Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey Hematology, May 16, 2013

5 Non-relapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation Biology of Blood and Marrow Transplantation, May 10, 2013

6 Late mortality after hematopoietic SCT for a childhood malignancy Bone Marrow Transplantation, May 15, 2013

7 Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation Hematological Oncology, May 1, 2013

8 The significance of cytomegalovirus viremia at day 100 or more following allogeneic hematopoietic stem cell transplantation Clinical Transplantation, May 7, 2013

9 Phase angle from BIA as a prognostic and nutritional status tool for children and adolescents undergoing hematopoietic stem cell transplantation Clinical Nutrition, May 10, 2013    Review Article

10 Allogeneic hematopoietic cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myeloma Bone Marrow Transplantation, April 3, 2013

11 Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM) Leukemia Research, May 10, 2013

12 Efficacy and Safety of Busulfan-Based Conditioning Regimens for Multiple Myeloma The Oncologist, May 2, 2013    Free full text    Review Article

13 A model for the regulation of T-type Ca2+ channels in proliferation: roles in stem cells and cancer Expert Review of Anticancer Therapy, May 7, 2013    Review Article

14 Increase of suicide and accidental death after hematopoietic stem cell transplantation Cancer, March 25, 2013

15 Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction Hematology, May 22, 2013

16 Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3-CD19 depletion Hematology, May 17, 2013

17 Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myeloid leukemia: a study from the cibmtr Biology of Blood and Marrow Transplantation, May 2, 2013

18 Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies Transplantation, May 28, 2013

19 Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplantation in Adults using Fludarabine, BCNU, Melphalan, and Antithymocyte Globulin (FBM-A): Outcomes depend on Disease Risk Index but not Age, Comorbidity Score, Donor Type, or HLA Mismatch Biology of Blood and Marrow Transplantation, May 13, 2013

20 Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases International Journal of Cancer, May 6, 2013